The abstract is read at the publisher; the summary is JClub's.
Combining phage Abs1 with recombinant capsule depolymerases enables infection of capsulated Acinetobacter baumannii in a murine bacteremia model, significantly reducing bacterial burden.
- Why it matters: Capsule-mediated shielding blocks phage access to the conserved OprC receptor, limiting phage control of clinically relevant capsulated strains.
- What they did: The study characterized phage Abs1 that targets the outer-membrane receptor OprC, then paired it with recombinant depolymerases against major A. baumannii capsule types in mice.
- The result: In the murine bacteremia model, the combination significantly reduced bacterial burden across diverse capsulated A. baumannii strains, suggesting depolymerases can unmask the receptor for phage activity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.